Van Tellingen O - Search Results

1

Cognitive impact of cytotoxic agents in mice.

Seigers R, Loos M, Van Tellingen O, Boogerd W, Smit AB, Schagen SB. Seigers R, et al. Among authors: van tellingen o. Psychopharmacology (Berl). 2015 Jan;232(1):17-37. doi: 10.1007/s00213-014-3636-9. Epub 2014 Jun 4. Psychopharmacology (Berl). 2015. PMID: 24894481

2

The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissue.

van Tellingen O, Boogerd W, Nooijen WJ, Beijnen JH. van Tellingen O, et al. Cancer Chemother Pharmacol. 1997;40(4):330-4. doi: 10.1007/s002800050665. Cancer Chemother Pharmacol. 1997. PMID: 9225951

3

Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.

Kemper EM, van Zandbergen AE, Cleypool C, Mos HA, Boogerd W, Beijnen JH, van Tellingen O. Kemper EM, et al. Among authors: van zandbergen ae, van tellingen o. Clin Cancer Res. 2003 Jul;9(7):2849-55. Clin Cancer Res. 2003. PMID: 12855665

4

The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice.

Kemper EM, Cleypool C, Boogerd W, Beijnen JH, van Tellingen O. Kemper EM, et al. Among authors: van tellingen o. Cancer Chemother Pharmacol. 2004 Feb;53(2):173-8. doi: 10.1007/s00280-003-0720-y. Epub 2003 Nov 7. Cancer Chemother Pharmacol. 2004. PMID: 14605863

5

Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein.

Kemper EM, Verheij M, Boogerd W, Beijnen JH, van Tellingen O. Kemper EM, et al. Among authors: van tellingen o. Eur J Cancer. 2004 May;40(8):1269-74. doi: 10.1016/j.ejca.2004.01.024. Eur J Cancer. 2004. PMID: 15110893

6

Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?

Kemper EM, Boogerd W, Thuis I, Beijnen JH, van Tellingen O. Kemper EM, et al. Among authors: van tellingen o. Cancer Treat Rev. 2004 Aug;30(5):415-23. doi: 10.1016/j.ctrv.2004.04.001. Cancer Treat Rev. 2004. PMID: 15245774 Review.

7

Blood-brain barrier and chemotherapeutic treatment of brain tumors.

de Vries NA, Beijnen JH, Boogerd W, van Tellingen O. de Vries NA, et al. Among authors: van tellingen o. Expert Rev Neurother. 2006 Aug;6(8):1199-209. doi: 10.1586/14737175.6.8.1199. Expert Rev Neurother. 2006. PMID: 16893347 Review.

8

Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies.

Kemper EM, Leenders W, Küsters B, Lyons S, Buckle T, Heerschap A, Boogerd W, Beijnen JH, van Tellingen O. Kemper EM, et al. Among authors: van tellingen o. Eur J Cancer. 2006 Dec;42(18):3294-303. doi: 10.1016/j.ejca.2006.07.013. Epub 2006 Oct 5. Eur J Cancer. 2006. PMID: 17027258

9

Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat.

Seigers R, Schagen SB, Beerling W, Boogerd W, van Tellingen O, van Dam FS, Koolhaas JM, Buwalda B. Seigers R, et al. Among authors: van dam fs, van tellingen o. Behav Brain Res. 2008 Jan 25;186(2):168-75. doi: 10.1016/j.bbr.2007.08.004. Epub 2007 Aug 10. Behav Brain Res. 2008. PMID: 17854921

10

Chemotherapy-related cognitive dysfunction: current animal studies and future directions.

Seigers R, Schagen SB, Van Tellingen O, Dietrich J. Seigers R, et al. Among authors: van tellingen o. Brain Imaging Behav. 2013 Dec;7(4):453-9. doi: 10.1007/s11682-013-9250-3. Brain Imaging Behav. 2013. PMID: 23949877 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters